SCHEMBL19089313

SCHEMBL19089313

C=CC(=O)Nc1cc(Nc2nccc(N)n2)c(OC)cc1N(C)CCN(C)C

nearest known ligand 0.72

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
EGFR P00533 20/20 0.72
ALK Q9UM73 2/20 0.69
KCNH2 Q12809 1/20 0.69
EML4 Q9HC35 1/20 0.68

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24251692 0.89 EGFR (0.69) EGFRALKKCNH2EML4
SCHEMBL17857068 0.87 EGFR (0.69) EGFRALKKCNH2EML4
SCHEMBL19440571 0.86 EGFR (0.69) EGFRALKKCNH2EML4
SCHEMBL19089663 0.85 EGFR (0.82) EGFRALKKCNH2EML4
SCHEMBL17373148 0.85 EGFR (0.67) EGFRALKKCNH2EML4
SCHEMBL17683089 0.85 EGFR (0.77) EGFRALKEML4
SCHEMBL20655995 0.85 EGFR (0.77) EGFRALKKCNH2EML4
SCHEMBL23937949 0.84 EGFR (0.66) EGFRALKKCNH2EML4
SCHEMBL26474195 0.84 EGFR (0.65) EGFRALKKCNH2EML4
SCHEMBL20892583 0.84 EGFR (0.70) EGFRALKKCNH2EML4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3205650-B1 EGFR INHIBITOR, AND PREPARATION AND APPLICATION THEREOF SHANGHAI HANSOH BIOMEDICAL CO LTD (CN) 2021-08-04 EP disclosed
WO-2017114500-A1 ACRYLANILIDE DERIVATIVE, PREPARATION METHOD THEREFOR, AND APPLICATIONS THEREOF IN PHARMACY 恩瑞生物医药科技(上海)有限公司 2017-07-06 WO disclosed